On top of that, the pharmacology from the Lively factors was mostly uncharacterized, and confirmation of SCB use was hindered by an absence of recognized biomarkers. These understanding gaps prompted scientists across multiple disciplines to rapidly (1) keep an eye on, recognize and quantify with chromatography/mass spectrometry the at any time-cha… Read More